HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Is Not Associated with SNP rs12979860 of the IL-28B Gene

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Vallinoto, Antonio C R ^a   Santana, Bárbara Brasil ^a   Sá, Keyla S G ^a   Ferreira, Tuane C S ^a   Sousa, Rita Catarina M ^a   Azevedo, Vânia N ^a   Feitosa, Rosimar N M ^a   Machado, Luiz Fernando A ^a   Ishak, Marluísa O G ^a   Ishak, Ricardo ^a  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 28B; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; IL28B PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ARTICLE; BRAZIL; CD4+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE SUBPOPULATION; TROPICAL SPASTIC PARAPARESIS; VIRUS LOAD; CD4 CD8 RATIO; GENETICS; IMMUNOLOGY;

CD4-CD8 RATIO; CYTOKINES; GENE FREQUENCY; HUMANS; INTERLEUKINS; PARAPARESIS, TROPICAL SPASTIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84947483813     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/804167     Document Type: Article

References (34)

1. B. J. Poiesz, F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo, "Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma," Proceedings of the National Academy of Sciences of the United States of America, vol. 77, no. 12, pp. 7415-7419, 1980.
2. A. Gessain and O. Cassar, "Epidemiological aspects and world distribution ofHTLV-1 infection," Frontiers inMicrobiology, vol. 3, article 388, 2012.
3. A. Gessain andG. deThé, "Geographic andmolecular epidemiology of primate T lymphotropic retroviruses: HTLV-I, HTLVII, STLV-I, STLV-PP, and PTLV-L," Advances in Virus Research, vol. 47, pp. 377-426, 1996.
4. F. A. Proietti, A. B. F. Carneiro-Proietti, B. C. Catalan-Soares, and E. L. Murphy, "Global epidemiology of HTLV-I infection and associated diseases," Oncogene, vol. 24, no. 39, pp. 6058-6068, 2005.
5. W. A. Blattner, D. W. Blayney, M. Robert-Guroff et al., "Epidemiology of human T-cell leukemia/lymphoma virus," Journal of Infectious Diseases, vol. 147, no. 3, pp. 406-416, 1983.
6. C. R.M. Bangham, "The immune response toHTLV-I," Current Opinion in Immunology, vol. 12, no. 4, pp. 397-402, 2000.
7. M. Osame, K. Usuku, S. Izumo et al., "HTLV-I associated myelopathy, a new clinical entity," The Lancet, vol. 327, no. 8488, pp. 1031-1032, 1986.
8. M. Taghaddosi, S. A. R. Rezaee, H. Rafatpanah, T. Rajaei, R. F. Hosseini, and V. Narges, "Association between HLA class I alleles and proviral load in HTLV-I associated myelopathy/tropical spastic paraperesis (HAM/TSP) patients in Iranian population," Iranian Journal of BasicMedical Sciences, vol. 16, no. 3, pp. 264-267, 2013.
9. A. Trevino, J. L. Vicario, M. Lopez et al., "Association between HLA alleles and HAM/TSP in individuals infected with HTLV-1," Journal of Neurology, vol. 260, no. 10, pp. 2551-2555, 2013.
10. A. C. R. Vallinoto, B. B. Santana, E. L. dos Santos et al., "FAS-670A/G single nucleotide polymorphism may be associated with human T lymphotropic virus-1 infection and clinical evolution to TSP/HAM," Virus Research, vol. 163, no. 1, pp. 178-182, 2012.
11. M. Saito and C. R. M. Bangham, "Immunopathogenesis of human T-cell leukemia virus type-1-associated myelopathy/ tropical spastic paraparesis: recent perspectives," Leukemia Research and Treatment, vol. 2012, Article ID 259045, 12 pages, 2012.
12. P. Sheppard,W. Kindsvogel,W.Xu et al., "IL-28, IL-29 and their class II cytokine receptor IL-28R," Nature Immunology, vol. 4, no. 1, pp. 63-68, 2003.
13. M. D. Robek, B. S. Boyd, and F. V. Chisari, "Lambda interferon inhibits hepatitis B and C virus replication," Journal of Virology, vol. 79, no. 6, pp. 3851-3854, 2005.
14. M. Mordstein, G. Kochs, L. Dumoutier et al., "Interferon- contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses," PLoS Pathogens, vol. 4, no. 9, Article ID e1000151, 2008.
15. N. Ank, M. B. Iversen, C. Bartholdy et al., "An important role for type III interferon (IFN-/IL-28) in TLR-induced antiviral activity," The Journal of Immunology, vol. 180, no. 4, pp. 2474-2485, 2008.
16. S. Kamihira, T. Usui, T. Ichikawa et al., "Paradoxical expression of IL-28B mRNA in peripheral blood in human T-cell leukemia virus Type-1 mono-infection and co-infection with hepatitis C virus," Virology Journal, vol. 9, article 40, 2012.
17. E. M.Coccia, M. Severa, E.Giacomini et al., "Viral infection and Toll-like receptor agonists induce a differential expression of type I and interferons in human plasmacytoid andmonocytederived dendritic cells," European Journal of Immunology, vol. 34, no. 3, pp. 796-805, 2004.
18. M. B. Iversen and S. R. Paludan, "Mechanisms of type III interferon expression," Journal of Interferon and Cytokine Research, vol. 30, no. 8, pp. 573-578, 2010.
19. H.-C. Lee, S. Narayanan, S.-J. Park, S.-Y. Seong, and Y. S. Hahn, "Transcriptional regulation of IFN- genes in hepatitis C virus-infected hepatocytes via IRF-3?IRF-7?NF-B complex," The Journal of Biological Chemistry, vol. 289, no.8,pp. 5310-5319, 2014.
20. K. Onoguchi, M. Yoneyama, A. Takemura et al., "Viral infections activate types I and III interferon genes through a common mechanism,"The Journal of Biological Chemistry, vol. 282, no. 10, pp. 7576-7581, 2007.
21. J. Sirén, J. Pirhonen, I. Julkunen, and S. Matikainen, "IFN- regulates TLR-dependent gene expression of IFN-, IFN-, IL-28, and IL-29," Journal of Immunology, vol. 174, no. 4, pp. 1932-1937, 2005.
22. N. Ank, H. West, C. Bartholdy, K. Eriksson, A. R. Thomsen, and S. R. Paludan, "Lambda interferon (IFN-), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo," Journal of Virology, vol. 80, no. 9, pp. 4501-4509, 2006.
23. S. V. Kotenko, G. Gallagher, V. V. Baurin et al., "IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex," Nature Immunology, vol. 4, no. 1, pp. 69-77, 2003.
24. A. Trevino, M. Lopez, E. Vispo et al., "Development of tropical spastic paraparesis in human T-lymphotropic virus type 1 carriers is influenced by interleukin 28B gene polymorphisms," Clinical Infectious Diseases, vol. 55, no. 1, pp. e1-e4, 2012.
25. S. S. Sanabani, Y. Nukui, J. Pereira et al., "Lack of evidence to support the association of a single IL28B genotype SNP rs12979860 with the HTLV-1 clinical outcomes and proviral load," BMC Infectious Diseases, vol. 12, article 374, 2012.
26. A. C. R. Vallinoto, M. O. G. Ishak, V. N. Azevedo et al., "Molecular epidemiology of human T-lymphotropic virus type II infection in Amerindian and urban populations of the Amazon region of Brazil," Human Biology, vol. 74, no. 5, pp. 633-644, 2002.
27. C. M. De Castro-Costa, A. Q. C. Aráujo, M. M. Barreto et al., "Proposal for diagnostic criteria of tropical spastic paraparesis/ HTLV-I-associated myelopathy (TSP/HAM)," AIDS Research and Human Retroviruses, vol. 22, no. 10, pp. 931-935, 2006.
28. B. P. Tamegao-Lopes, P. R. Rezende, L. M. C. Maradei-Pereira, and J. A. R. De Lemos, "HTLV-1 and HTLV-2 proviral load: a simple method using quantitative real-time PCR," Revista da Sociedade Brasileira deMedicinaTropical, vol. 39,no. 6, pp. 548-552, 2006.
29. M. Ayres, J. R. Ayres, D. L. M. Ayres, and A. S. Santos, BIOSTAT 5.0: Aplicaçoes Estatesticas nas Areas das Ciencias Bioĺogicas e Médicas, Sociedade Civil Mamiraúa/MCT-CNPq/Conservation International, Belém, Brazil, 2007.
30. S. Ahmadi Ghezeldasht, A. Shirdel, M. A. Assarehzadegan et al., "Human T lymphotropic virus type I (HTLV-I) oncogenesis: molecular aspects of virus and host interactions in pathogenesis of adult T cell leukemia/lymphoma (ATL)," Iranian Journal of Basic Medical Sciences, vol. 16, no. 3, pp. 179-195, 2013.
31. G. S. Pontes, B. Tamegao-Lopes, L. F. A. Machado et al., "Characterization of mannose-binding lectin gene polymorphism among human T-cell lymphotropic virus 1 and 2-infected asymptomatic subjects," Human Immunology, vol. 66, no. 8, pp. 892-896, 2005.
32. A. L. B. Starling, O. A. Martins-Filho, J. R. Lambertucci et al., "Proviral load and the balance of serum cytocines in HTLV-1-asymptomatic infection and in HTLV-1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP)," Acta Tropica, vol. 125, no. 1, pp. 75-81, 2013.
33. C. R. M. Bangham and M. Osame, "Cellular immune response to HTLV-1," Oncogene, vol. 24, no. 39, pp. 6035-6046, 2005.
34. R. B. Lal and D. L. Rudolph, "Constitutive production of interleukin-6 and tumor necrosis factor- from spontaneously proliferating T cells in patients with human T-cell lymphotropic virus type-I/II," Blood, vol. 78, no. 3, pp. 571-574, 1991.